Invention Grant
- Patent Title: Thiazolidine derivatives as orexin receptor antagonists
- Patent Title (中): 噻唑烷衍生物作为食欲素受体拮抗剂
-
Application No.: US12593095Application Date: 2008-03-25
-
Publication No.: US08236964B2Publication Date: 2012-08-07
- Inventor: Hamed Aissaoui , Christoph Boss , Markus Gude , Ralf Koberstein , Thierry Sifferlen
- Applicant: Hamed Aissaoui , Christoph Boss , Markus Gude , Ralf Koberstein , Thierry Sifferlen
- Applicant Address: CH Allschwil
- Assignee: Actelion Pharmaceuticals Ltd.
- Current Assignee: Actelion Pharmaceuticals Ltd.
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Associates LLC
- Priority: WOPCT/IB2007/051048 20070326; WOPCT/IB2008/050620 20080221
- International Application: PCT/IB2008/051110 WO 20080325
- International Announcement: WO2008/117241 WO 20081002
- Main IPC: A61K31/427
- IPC: A61K31/427 ; C07D417/12 ; C07D417/14
Abstract:
The invention relates to novel thiazolidine derivatives of the formula (I) wherein A and R1 are as described in the description and their use as medicaments, especially as orexin receptor antagonists.
Public/Granted literature
- US20100113531A1 THIAZOLIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS Public/Granted day:2010-05-06
Information query
IPC分类:
